Threadneedle Likes AZN's Growth Drivers29 Jul 2021 08:51
Just thought you might all appreciate a positive news feed this morning...
Richard Colwell, manager of Threadneedle UK Equity Income, says there are ‘several growth drivers’ at AstraZeneca (AZN).The pharmaceutical giant is Colwell’s top holding, making up 8.3% of the £3.8bn portfolio, and in his latest monthly update he said it had been a ‘notable’ contributor to performance in June.‘AstraZeneca benefited from further encouraging developments about its product pipeline, relating to a kidney disease treatment and a drug to treat a form of respiratory virus in children,’ he said.‘AstraZeneca has the best sales and earnings growth profile in the European large-cap pharmaceutical space, with several growth drivers.’Shares in AstraZeneca closed up 0.2%, or 13p, at £82.66 on Wednesday, meaning they have fallen back about 5% in July so far.
Let's hope for some growth in the SP then!